|National PMTCT programme begins after Constitutional Court judgement against the Government:|
•Single dose nevirapine to the mother in labour, and to the infant within 72 h of birth.
|AZT to mother from 28 weeks gestation; single dose nevirapine to mother in labour and to infant within 72 h of birth and HAART for pregnant women.||2004|
|•AZT from 14 weeks gestation: single dose nevirapine plus tenofovir/3TC in labour; infant prophylaxis with nevirapine for 6 weeks if mother on HAART or formula feeding, or until the end of all breastfeeding if mother not eligible for HAART.||2010|
|•All pregnant women eligible for HAART, irrespective of CD4 count. Infant prophylaxis with nevirapine for 6 weeks. Women initiating HAART with CD4 < 350 and no other indication for HAART, to stop treatment after all breastfeeding has ceased.||2013|
|•All pregnant and breastfeeding women eligible for lifelong HAART.||2015|